Press Releases

August 11, 2022

Panbela Announces 1st Patient Enrolled in its Aspire Trial Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

View/download press release »

Sign up to receive press releases via email